ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $796,736 | -18.8% | 146,190 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $980,935 | -24.0% | 146,190 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $1,290,858 | +15.6% | 146,190 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,116,892 | +4.2% | 146,190 | -2.9% | 0.00% | 0.0% |
Q3 2022 | $1,072,000 | -12.0% | 150,500 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,218,000 | -55.1% | 150,500 | -23.0% | 0.00% | -50.0% |
Q1 2022 | $2,714,000 | -51.8% | 195,500 | -2.5% | 0.00% | -50.0% |
Q4 2021 | $5,626,000 | -19.5% | 200,500 | -2.4% | 0.00% | -20.0% |
Q3 2021 | $6,985,000 | -22.1% | 205,500 | -6.4% | 0.01% | -16.7% |
Q2 2021 | $8,969,000 | +5.8% | 219,500 | +4.3% | 0.01% | 0.0% |
Q1 2021 | $8,475,000 | +11.5% | 210,500 | +63.8% | 0.01% | 0.0% |
Q4 2020 | $7,598,000 | -9.4% | 128,500 | -25.5% | 0.01% | -14.3% |
Q3 2020 | $8,389,000 | +15.2% | 172,500 | +14.6% | 0.01% | +16.7% |
Q2 2020 | $7,281,000 | +74.1% | 150,500 | 0.0% | 0.01% | +50.0% |
Q1 2020 | $4,181,000 | – | 150,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |